Neurostimulator Implantation for Hereditary and Idiopathic Neuropathy

Medical Necessity Assessment

The patient meets all required criteria for spinal cord stimulator implantation, including failed 6+ months of conservative treatments, completed psychological evaluation, no contraindications, objective findings of pathology, and severe disability documented on Oswestry Disability Index 1
The patient demonstrated exceptional response during the trial period, with 80-90% pain reduction, reduced pain medication, and improved activity level and sleep pattern 1

Spinal cord stimulation is an established treatment for peripheral neuropathic pain that has failed to respond to conventional therapies, with the American Society of Anesthesiologists guidelines supporting its use 1, 2
First-line therapies for neuropathic pain include tricyclic antidepressants, serotonin-norepinephrine reuptake inhibitors, anticonvulsants, and physical therapy 1, 2
Second-line therapies include opioid agonists as combination therapy and topical agents 2

Chronic tissue interfacing with implanted devices involves varying degrees of foreign body reaction and encapsulation with scar/fibrotic tissue, which may increase stimulation thresholds over time 3
For diabetic patients, careful monitoring of glycemic control is recommended as it may impact neuropathic symptoms 1

The proposed implantation of neurostimulator is medically necessary for this patient with hereditary and idiopathic neuropathy, based on comprehensive evaluation of the patient's condition, failed conservative treatments, and successful trial 1, 2, 3